BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6870092)

  • 1. [Rendu-Osler-Weber disease. Diagnostic and therapeutic assessment by angiography].
    Lasjaunias P; Appel B; Carrière T
    Ann Otolaryngol Chir Cervicofac; 1983; 100(3):203-15. PubMed ID: 6870092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of superselective embolization of the maxillary artery in treatment of bleedings in the Rendu-Osler-Weber syndrome].
    Kantor I; Winiarski M; Jurkiewicz D; Osiecki M; Brzozowski K
    Otolaryngol Pol; 2005; 59(2):215-7. PubMed ID: 16095090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Embolization of branches of the external carotid artery in nosebleeds complicating Rendu-Osler-Weber disease].
    Nekipelov EF; Serbinenko FA
    Zh Vopr Neirokhir Im N N Burdenko; 1983; (4):23-33. PubMed ID: 6624354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Critical evaluation of vascular embolization in patients with Rendu-Osler disease].
    Fischer M; Dietrich U; Labisch C; Zanella FE; Jahnke K
    Laryngorhinootologie; 1997 Aug; 76(8):490-4. PubMed ID: 9376033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic embolization for control of epistaxis in a patient with hereditary hemorrhagic telangiectasia.
    Weissman JL; Jungreis CA; Johnson JT
    Am J Otolaryngol; 1995; 16(2):138-40. PubMed ID: 7793510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intractable epistaxis in Osler-Rendu-Weber syndrome].
    Zalagh M; Errami N; Bouaity B; Hemmaoui B; Itoua W; Benariba F
    Rev Stomatol Chir Maxillofac; 2011 Nov; 112(5):310-2. PubMed ID: 21940027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epistaxis in Rendu-Osler-Weber disease treated with selective embolization--case report].
    Jarzabek M; Trojanowski P; Szajner M; Pyra K; Sojka M; Szczerbo-Trojanowska M
    Przegl Lek; 2012; 69(7):317-9. PubMed ID: 23276024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epistaxis in patients with hereditary hemorrhagic telangiectasia treated with selective arterial embolization.
    Trojanowski P; Jargiello T; Trojanowska A; Klatka J
    Acta Radiol; 2011 Oct; 52(8):846-9. PubMed ID: 21816895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osler-Weber-Rendu syndrome.
    Mani BI; Rubel AR; Chauhdary WA; Bashir A; Soe ZN; Javed N; Sharif SMA; Hla Aye MT; Chong VH
    QJM; 2020 Aug; 113(8):586-587. PubMed ID: 32170936
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of cerebral aneurysms and arteriovenous vascular malformations in hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease)].
    Helmchen C; Nahser HC; Yousry T; Witt TN; Kühne D
    Nervenarzt; 1995 Feb; 66(2):124-8. PubMed ID: 7715751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous embolization to control epistaxis in Rendu-Osler-Weber disease.
    Strother CM; Newton TH
    Arch Otolaryngol; 1976 Jan; 102(1):58-60. PubMed ID: 1244834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osler-Weber-Rendu disease: a six generation family.
    Cheng LH; Tsai WJ
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Sep; 8(9):495-502. PubMed ID: 1294765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rendu-Osler-Weber disease].
    Sys L; van den Hoogen FJ
    Ned Tijdschr Tandheelkd; 2005 Sep; 112(9):336-9. PubMed ID: 16184912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rendu-Osler disease. Follow-up of 6 patients treated by embolization. Nasal telecobaltotherapy in a refractory case].
    Esparcia Navarro M; Ferrer Baixauli F; Moya Albiol S; Vento Torres D; García Callejo FJ; Soler Marquessins F; Marco Algarra J
    Acta Otorrinolaringol Esp; 1999 Apr; 50(3):197-201. PubMed ID: 10362862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Percutaneous therapeutic embolization in therapy refractory, non-traumatic epistaxis].
    Kramann B; Roth R; Schneider G; Uder M; Federspil P; Iro H
    HNO; 1998 Dec; 46(12):973-9. PubMed ID: 10023591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
    Hanks JE; Hunter D; Goding GS; Boyer HC
    Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Maxillary artery embolisation as a method of treatment of hemorrhages in Rendu-Osler-Weber Syndrome--our experience].
    Barnaś S; Wilczyński K; Kiszka M; Gerber-Sekula A; Nowicki J
    Otolaryngol Pol; 2007; 61(5):884-6. PubMed ID: 18552041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pial arteriovenous fistula in children as presenting manifestation of Rendu-Osler-Weber disease.
    García-Mónaco R; Taylor W; Rodesch G; Alvarez H; Burrows P; Coubes P; Lasjaunias P
    Neuroradiology; 1995 Jan; 37(1):60-4. PubMed ID: 7708192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rendu-Osler disease and recurrent thromboembolic venous disease].
    Ben Salah R; Frikha F; Chebbi D; Chabchoub I; Bahloul Z
    J Med Vasc; 2019 Feb; 44(1):76-78. PubMed ID: 30770085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A new sclerosant for the treatment of Rendu-Osler-Weber disease].
    Ramírez B; Morais D; Condado MA; Marcos M; Martín G; Poncela M
    Acta Otorrinolaringol Esp; 2000; 51(1):36-9. PubMed ID: 10799930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.